Familiar Anti-Inflammatory Felled by Strokes in TAVR Trial

(MedPage Today) — The inflammation suppressant colchicine could show more promise in transcatheter aortic valve replacement (TAVR) — if not for excess strokes, as seen in one small randomized study.
In the Co-STAR double-blind trial, periprocedural…